首页> 外文期刊>Diabetes >Treatment of type 2 diabetes by adenoviral-mediated overexpression of the glucokinase regulatory protein
【24h】

Treatment of type 2 diabetes by adenoviral-mediated overexpression of the glucokinase regulatory protein

机译:腺病毒介导的葡萄糖激酶调节蛋白的过表达治疗2型糖尿病

获取原文
获取原文并翻译 | 示例
           

摘要

The enzyme glucokinase(GK)plays a central role in glucose homeostasis. Hepatic GK activity is acutely controlled by the action of the GK regulatory protein (GKRP). In vitro evidence suggests that GKRP revers- ibly binds to GK and inhibits its activity; however, less is known about the in vivo function of GKRP. To further explore the physiological role of GKRP in vivo, we used an E1/E2a/E3-deficient adenoviral vector containing the cDNA encoding human GKRP(Av3hGKRP).
机译:葡萄糖激酶(GK)在葡萄糖稳态中起着核心作用。肝GK活性受GK调节蛋白(GKRP)的作用急性控制。体外证据表明,GKRP可逆地与GK结合并抑制其活性。然而,人们对GKRP的体内功能知之甚少。为了进一步探讨GKRP在体内的生理作用,我们使用了一种E1 / E2a / E3缺陷型腺病毒载体,该载体包含编码人GKRP(Av3hGKRP)的cDNA。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号